Cleveland Clinic reports promising results for breast cancer vaccine from final Phase
Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
Threaded Mode